Literature DB >> 18511475

The incidence of rheumatoid arthritis in Spain: results from a nationwide primary care registry.

J Carbonell1, T Cobo, A Balsa, M A Descalzo, L Carmona.   

Abstract

OBJECTIVE: To estimate the incidence of early arthritis (EA) and of RA in adults (>16 yrs) in Spain.
METHODS: Primary care physicians were instructed in the detection of new cases using a checklist. All cases were evaluated at EA units (EAUs) within 15 days of detection. ACR criteria for the classification of RA were assessed every 6 months thereafter.
RESULTS: In an area covering 4,342,378 inhabitants over the age of 16 yrs, 2467 patients were referred to the EAU, of whom 1063 fulfilled EA criteria (43.1%). After 6 months, 362 patients fulfilled RA criteria. The estimated annual incidence of EA was 25/100,000 population (95% CI: 23, 26). The annual incidence of RA was 8.3 cases/100,000 (95% CI: 7.5, 9.2): 11.3/100,000 in women (95% CI: 10.0, 12.8), and 5.2/100,000 in men (95% CI: 4.3, 6.3). The incidence of RA increased with age in both sexes. At the 6 months' assessment, 187 (51.7%) of the patients with RA were RF positive. The presentation of RA was mainly polyarticular (n = 268; 74.0%). There were 701/1063 patients with EA who did not fulfil RA criteria by 6 months after the first rheumatologist visit. If all cases of undifferentiated arthritis (n = 118; 17%) became RA, the incidence would be in the range of 10 cases/100,000 population.
CONCLUSIONS: RA incidence in Spain is in the lower range of published data. The incidence of EA is about three times that of RA.

Entities:  

Mesh:

Year:  2008        PMID: 18511475     DOI: 10.1093/rheumatology/ken205

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  31 in total

1.  Smartphone application for rheumatoid arthritis self-management: cross-sectional study revealed the usefulness, willingness to use and patients' needs.

Authors:  Rita Azevedo; Miguel Bernardes; João Fonseca; Aurea Lima
Journal:  Rheumatol Int       Date:  2015-04-24       Impact factor: 2.631

Review 2.  The epidemiology of early inflammatory arthritis.

Authors:  Johanna M W Hazes; Jolanda J Luime
Journal:  Nat Rev Rheumatol       Date:  2011-06-14       Impact factor: 20.543

3.  Prevalence and incidence of rheumatoid arthritis in Italy.

Authors:  Maurizio Rossini; Elisa Rossi; Davide Bernardi; Ombretta Viapiana; Davide Gatti; Luca Idolazzi; Cristian Caimmi; Marisa Derosa; Silvano Adami
Journal:  Rheumatol Int       Date:  2014-03-09       Impact factor: 2.631

Review 4.  An autumn tale: geriatric rheumatoid arthritis.

Authors:  Senol Kobak; Cemal Bes
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-11-07       Impact factor: 5.346

Review 5.  Safety and Efficacy of Biological Disease-Modifying Antirheumatic Drugs in Older Rheumatoid Arthritis Patients: Staying the Distance.

Authors:  Alla Ishchenko; Rik J Lories
Journal:  Drugs Aging       Date:  2016-06       Impact factor: 3.923

6.  Cost-effectiveness of clinical remission by treat to target strategy in established rheumatoid arthritis: results of the CREATE registry.

Authors:  M Cárdenas; S de la Fuente; M C Castro-Villegas; M Romero-Gómez; D Ruiz-Vílchez; J Calvo-Gutiérrez; A Escudero-Contreras; J R Del Prado; E Collantes-Estévez; P Font
Journal:  Rheumatol Int       Date:  2016-10-24       Impact factor: 2.631

7.  Clinical and therapeutic management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: RADAR study.

Authors:  Antonio Gomez-Centeno; Esteban Rubio-Romero; Juan Gabriel Ovalles; Sara Manrique-Arija; Sara Marsal-Barril; Juan Amarelo-Ramos; Javier Del Pino-Montes; Santiago Muñoz-Fernández; Sagrario Bustabad; Ceferino Barbazán-Álvarez
Journal:  Rheumatol Int       Date:  2019-08-08       Impact factor: 2.631

8.  Real-world cost-effectiveness of infliximab, etanercept and adalimumab in rheumatoid arthritis patients: results of the CREATE registry.

Authors:  M Cárdenas; S de la Fuente; P Font; M C Castro-Villegas; M Romero-Gómez; D Ruiz-Vílchez; J Calvo-Gutiérez; A Escudero-Contreras; M A Casado; J R Del Prado; E Collantes-Estévez
Journal:  Rheumatol Int       Date:  2016-02       Impact factor: 2.631

9.  Quality-of-care standards for early arthritis clinics.

Authors:  José Andrés Román Ivorra; Juan Antonio Martínez; Pablo Lázaro; Federico Navarro; Antonio Fernandez-Nebro; Eugenio de Miguel; Estibaliz Loza; Loreto Carmona
Journal:  Rheumatol Int       Date:  2013-04-09       Impact factor: 2.631

Review 10.  Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.

Authors:  Sherine E Gabriel; Kaleb Michaud
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.